EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 34 (October 2018) Focus issue F1 Med Sci (Paris), 34 (2018) 26-32 References
Free Access
Issue
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 26 - 32
DOI https://doi.org/10.1051/medsci/201834f105
Published online 07 November 2018
  1. Charles MP, Kali A, Easow JM, Joseph NM, Ravishankar M, Srinivasan S, et al. Ventilator-associated pneumonia. Australasian Med J 2014 ; 7 : 334–344. [CrossRef] [Google Scholar]
  2. Guillamet CV, Kollef MH. Update on ventilator-associated pneumonia. Curr Opin Crit Care 2015 ; 21 : 430–438. [CrossRef] [PubMed] [Google Scholar]
  3. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vesin A, Garrouste-OrgeasM, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011 ; 184 : 1133–1139. [CrossRef] [PubMed] [Google Scholar]
  4. de Pont AC. Attributable mortality of ventilator-associated pneumonia. Lancet Infect Dis 2013 ; 13 : 1014. [CrossRef] [PubMed] [Google Scholar]
  5. Timsit JF, Zahar JR, Chevret S. Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 2011 ; 17 : 464–471. [CrossRef] [PubMed] [Google Scholar]
  6. Eagye KJ, Nicolau DP, Kuti JL. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia. Semin Resp Crit Care Med 2009 ; 30 : 116–123. [CrossRef] [Google Scholar]
  7. Kappstein I, Schulgen G, Beyer U, Geiger K, Schumacher M, Daschner FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992 ; 11 : 504–508. [CrossRef] [PubMed] [Google Scholar]
  8. Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Pharmacotherapy 2010 ; 30 : 453–462. [CrossRef] [PubMed] [Google Scholar]
  9. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999 ; 81 : 417–421. [CrossRef] [PubMed] [Google Scholar]
  10. Dominguez-Comesana E, Estevez-Fernandez SM, Lopez-Gomez V, Ballinas-Miranda J, Dominguez-Fernandez R. Procalcitonin and C-reactive protein as early markers of postoperative intra-abdominal infection in patients operated on colorectal cancer. Int J Colorect Dis 2017. [Google Scholar]
  11. Tachyla SA, Marochkov AV, Lipnitski AL, Nikiforova YG. The prognostic value of procalcitonin, C-reactive protein and cholesterol in patients with an infection and multiple organ dysfunction. Korean J Anesthesiol 2017 ; 70 : 305–310. [CrossRef] [PubMed] [Google Scholar]
  12. Habib SF, Mukhtar AM, Abdelreheem HM, Khorshied MM, El Sayed R, Hafez MH, et al. Diagnostic values of CD64, C-reactive protein and procalcitonin in ventilator-associated pneumonia in adult trauma patients: a pilot study. Clin Chem Lab Med 2016 ; 54 : 889–895. [CrossRef] [PubMed] [Google Scholar]
  13. Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008 ; 45 : 293–298. [CrossRef] [Google Scholar]
  14. Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis 2010 ; 51 : suppl 1 S131–S135. [CrossRef] [PubMed] [Google Scholar]
  15. Allaouchiche B, Jaumain H, Dumontet C, Motin J. Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid?. Chest 1996 ; 110 : 1558–1565. [CrossRef] [PubMed] [Google Scholar]
  16. Mongodi S, Via G, Girard M, Rouquette I, Misset B, Braschi A, et al. Lung Ultrasound for Early Diagnosis of Ventilator-Associated Pneumonia. Chest 2016 ; 149 : 969–980. [CrossRef] [PubMed] [Google Scholar]
  17. Lauzier F, Ruest A, Cook D, Dodek P, Albert M, Shorr AF, et al. The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care 2008 ; 23 : 50–57. [CrossRef] [PubMed] [Google Scholar]
  18. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic „blind“ bronchoalveolar lavage fluid. Am Rev Respir Dis 1991 ; 143 : 1121–1129. [CrossRef] [PubMed] [Google Scholar]
  19. Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995 ; 152 : 1982–1991. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.